|
|
||||||||
The Annals of Thoracic Surgery, Vol 51, 219-224, Copyright © 1991 by The Society of Thoracic Surgeons
LA Lanza, JB Putnam Jr, RS Benjamin and JA Roth
Between 1979 and 1988, 26 patients with pulmonary metastases from adult
soft-tissue sarcomas were treated with Adriamycin (doxorubicin
hydrochloride), Cytoxan (cyclophosphamide), and DTIC before metastasectomy.
Thirty-eight thoracotomies were performed with postoperative complications
in 5 patients (5/38, 13.2%) and one postoperative death (1/38, 2.6%). Two
patients had benign lesions at thoracotomy and were excluded from further
survival analysis. The median survival of the remaining 24 patients after
thoracotomy was 18.5 +/- 5.9 months, and the actuarial 5-year survival was
22%. Five patients (5/24, 21%) achieved a clinically complete response with
preoperative chemotherapy, but all had recurrence in the lung and underwent
resection of pulmonary metastases. Seven patients (7/24, 29%) achieved a
partial response and had residual disease resected at thoracotomy. Twelve
patients (12/24, 50%) showed either no change or disease progression while
receiving chemotherapy and were referred for resection. Postthoracotomy
disease-free survival and postthoracotomy overall survival did not differ
significantly between the three groups. One patient in the group showing no
change or progression of disease while receiving chemotherapy is alive
without recurrence 57 months after initial pulmonary metastasectomy.
Chemotherapy can be used for the initial treatment of pulmonary metastases
from adult soft-tissue sarcomas. However, survival after resection of
pulmonary metastases cannot be accurately predicted based on the clinical
response to preoperative chemotherapy.
ARTICLES
Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases
Department of Thoracic Surgery, University of Texas MD Anderson Cancer Center, Houston.
This article has been cited by other articles:
![]() |
R. M. Suri, C. Deschamps, S. D. Cassivi, F. C. Nichols III, M. S. Allen, C. D. Schleck, and P. C. Pairolero Pulmonary Resection for Metastatic Malignant Fibrous Histiocytoma: An Analysis of Prognostic Factors Ann. Thorac. Surg., November 1, 2005; 80(5): 1847 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lee, C. H.R. Boasquevisque, M. M. Boglione, M. Hiratsuka, R. K. Scheule, J. D. Cooper, and G. A. Patterson Isolated lung liposome-mediated gene transfer produces organ-specific transgenic expression Ann. Thorac. Surg., September 1, 1998; 66(3): 903 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Furrer, D. Lardinois, W. Thormann, H.-J. Altermatt, D. Betticher, J. Triller, D. Mettler, U. Althaus, M. E. Burt, and H.-B. Ris Cytostatic Lung Perfusion by Use of an Endovascular Blood Flow Occlusion Technique Ann. Thorac. Surg., June 1, 1998; 65(6): 1523 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Furrer, D. Lardinois, W. Thormann, H. J. Altermatt, D. Betticher, T. Cerny, A. Fikrle, D. Mettler, U. Althaus, M. E. Burt, et al. Isolated Lung Perfusion: Single-Pass System Versus Recirculating Blood Perfusion in Pigs Ann. Thorac. Surg., May 1, 1998; 65(5): 1420 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abolhoda, A. Brooks, S. Nawata, Y. Kaneda, H. Cheng, and M. E. Burt Isolated Lung Perfusion With Doxorubicin Prolongs Survival in a Rodent Model of Pulmonary Metastases Ann. Thorac. Surg., July 1, 1997; 64(1): 181 - 184. [Abstract] [Full Text] |
||||
![]() |
S. Nawata, A. Abolhoda, H. M. Ross, A. Brooks, and M. E. Burt Sequential Bilateral Isolated Lung Perfusion in the Rat: An Experimental Model Ann. Thorac. Surg., March 1, 1997; 63(3): 796 - 799. [Abstract] [Full Text] |
||||
![]() |
S. Nawata, N. Abecasis, H. M. Ross, A. Abolhoda, H. Cheng, K. S. Sachar, and M. E. Burt ISOLATED LUNG PERFUSION WITH MELPHALAN FOR THE TREATMENT OF METASTATIC PULMONARY SARCOMA J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1542 - 1548. [Abstract] [Full Text] |
||||
![]() |
G. B. Ratto, S. Toma, D. Civalleri, G. C. Passerone, M. Esposito, D. Zaccheo, M. Canepa, P. Romano, R. Palumbo, F. De Cian, et al. ISOLATED LUNG PERFUSION WITH PLATINUM IN THE TREATMENT OF PULMONARY METASTASES FROM SOFT TISSUE SARCOMAS J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 614 - 622. [Abstract] [Full Text] |
||||
![]() |
B. Ng, S. N. Hochwald, and M. E. Burt Isolated Lung Perfusion With Doxorubicin Reduces Cardiac and Host Toxicities Associated With Systemic Administration Ann. Thorac. Surg., March 1, 1996; 61(3): 969 - 972. [Abstract] [Full Text] |
||||
![]() |
H.-Y. Wang, B. Ng, D. Blumberg, J. L. Port, S. N. Hochwald, and M. E. Burt Pulmonary Artery Perfusion of Doxorubicin With Blood Flow Occlusion: Pharmacokinetics and Treatment in a Metastatic Sarcoma Model Ann. Thorac. Surg., November 1, 1995; 60(5): 1390 - 1394. [Abstract] [Full Text] |
||||
![]() |
B. Weksler, B. Ng, J. T. Lenert, and M. E. Burt Isolated Single-Lung Perfusion: A Study of the Optimal Perfusate and Other Pharmacokinetic Factors Ann. Thorac. Surg., September 1, 1995; 60(3): 624 - 629. [Abstract] [Full Text] |
||||
![]() |
J. L. Port, S. N. Hochwald, H.-Y. Wang, and M. E. Burt Buthionine Sulfoximine Pretreatment Potentiates the Effect of Isolated Lung Perfusion With Doxorubicin Ann. Thorac. Surg., August 1, 1995; 60(2): 239 - 243. [Abstract] [Full Text] |
||||
![]() |
B. Weksler, J. Lenert, B. Ng, and M. Burt Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 50 - 54. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |